STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
30-11-2017

유효 성분:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

제공처:

Sanofi-Aventis Australia Pty Ltd

INN (국제 이름):

prochlorperazine mesilate

약제 형태:

Injection

구성:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

관리 경로:

Intramuscular

패키지 단위:

10 x 1 mL

처방전 유형:

(S1) This Schedule is intentionally blank

치료 징후:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

제품 요약:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2007-07-16